Stop CMV Act of 2025
Summary
The Stop CMV Act of 2025 aims to amend the Public Health Service Act, mandating congenital Cytomegalovirus (CMV) screening for newborns. It directs hospitals and healthcare entities to administer CMV tests to infants under 21 days old. The bill also outlines processes for states to prescribe testing standards and procedures, with federal oversight if states fail to do so within two years.
Expected Effects
The Act will likely increase the early detection of congenital CMV, potentially leading to earlier interventions and improved health outcomes for affected infants. It establishes a framework for states to implement screening programs, supported by federal grants and technical assistance. The National Institutes of Health (NIH) will also expand research and development efforts related to CMV screening, diagnostics, prevention, and treatment.
Potential Benefits
- Early detection of congenital CMV allows for timely intervention and treatment.
- Provides grants to states for administering CMV tests, improving healthcare access.
- Technical assistance to states for data collection and public education on CMV.
- Expands research and development on CMV screening techniques, diagnostics, and treatments.
- Could reduce the long-term health and developmental consequences of undetected CMV.
Potential Disadvantages
- Potential financial burden on hospitals and healthcare entities to administer the tests.
- Possible increase in healthcare costs due to additional screening and follow-up care.
- States may face challenges in developing and implementing effective screening programs.
- The Act relies on future appropriations, which may not be guaranteed.
- Potential for increased anxiety and stress for parents due to screening and potential false positives.
Constitutional Alignment
The Stop CMV Act aligns with the Constitution's general welfare clause (Preamble) by promoting public health through early disease detection and intervention. Congress's power to regulate interstate commerce (Article I, Section 8) justifies federal involvement in setting standards and providing grants to states for healthcare initiatives. The Act does not appear to infringe on any specific constitutional rights or limitations.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).